EPS Co., Ltd. (www.eps.co.jp/english) has unmatched access to, and experience with, investigators and regulatory agencies in Japan. This leading Japanese CRO has conducted studies in a variety of therapeutic areas such as oncology, cardiovascular, dermatology, endocrinology and neurology. Working together, EPS and PharmaLink provide seamless execution of clinical trials in Japan.

Advantage for PharmaLink: Extends our global reach to Japan.